APA

Haverkamp W., Breithardt G., Camm A. J., Janse M. J., Rosen M. R., Antzelevitch C., Escande D., Franz M., Malik M., Moss A. & Shah R. (20000929). The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. : Cardiovascular research.

Chicago

Haverkamp W, Breithardt G, Camm A J, Janse M J, Rosen M R, Antzelevitch C, Escande D, Franz M, Malik M, Moss A and Shah R. 20000929. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. : Cardiovascular research.

Harvard

Haverkamp W., Breithardt G., Camm A. J., Janse M. J., Rosen M. R., Antzelevitch C., Escande D., Franz M., Malik M., Moss A. and Shah R. (20000929). The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. : Cardiovascular research.

MLA

Haverkamp W, Breithardt G, Camm A J, Janse M J, Rosen M R, Antzelevitch C, Escande D, Franz M, Malik M, Moss A and Shah R. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. : Cardiovascular research. 20000929.